Vis enkel innførsel

dc.contributor.authorLlorente, Alicia
dc.contributor.authorErdbrügger, Uta
dc.contributor.authorBlijdorp, Charles J
dc.contributor.authorMartens-Uzunova, Elena S.
dc.date.accessioned2022-02-25T08:22:32Z
dc.date.available2022-02-25T08:22:32Z
dc.date.created2022-01-16T14:09:04Z
dc.date.issued2021-05-21
dc.identifier.issn2001-3078
dc.identifier.urihttps://hdl.handle.net/11250/2981365
dc.description.abstractUrine is commonly used for clinical diagnosis and biomedical research. The discovery of extracellular vesicles (EV) in urine opened a new fast-growing scientific field. In the last decade urinary extracellular vesicles (uEVs) were shown to mirror molecular processes as well as physiological and pathological conditions in kidney, urothelial and prostate tissue. Therefore, several methods to isolate and characterize uEVs have been developed. However, methodological aspects of EV separation and analysis, including normalization of results, need further optimization and standardization to foster scientific advances in uEV research and a subsequent successful translation into clinical practice. This position paper is written by the Urine Task Force of the Rigor and Standardization Subcommittee of ISEV consisting of nephrologists, urologists, cardiologists and biologists with active experience in uEV research. Our aim is to present the state of the art and identify challenges and gaps in current uEV-based analyses for clinical applications. Finally, recommendations for improved rigor, reproducibility and interoperability in uEV research are provided in order to facilitate advances in the field.en_US
dc.description.sponsorshipESM-U, CG, GV, GJ, IVB, MvR, and VvS, are members of the “IMMPROVE” consortium (Innovative Measurements and Markers for Prostate Cancer Diagnosis and Prognosis using Extracellular Vesicles), which is sponsored by an Alpe d'HuZes grant of the Dutch Cancer Society (grant #EMCR2015-8022). AL is supported by Norges Forskningsråd, Kreftforeningen and Helse Sør-Øst RHF (NO). UE is supported by the NIH, National Heart, Lung, and Blood Institute, Award number K23-HL-126101. CJB and EJH are supported by the Dutch Kidney Foundation (Nierstichting), Award number: CP18.05.en_US
dc.language.isoengen_US
dc.publisherWiley Open Accessen_US
dc.relation.ispartofseriesJournal of Extracellular Vesicles;Volume 10, Issue 7. May 2021 - e12093
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectBiobanksen_US
dc.subjectBiomarkersen_US
dc.subjectBladdersen_US
dc.subjectExtracellular vesiclesen_US
dc.subjectKidneysen_US
dc.subjectProstateen_US
dc.subjectUrineen_US
dc.titleUrinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesiclesen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2021 The Authorsen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttps://doi.org/10.1002/jev2.12093
dc.identifier.cristin1981955
dc.source.journalJournal of Extracellular Vesiclesen_US
dc.source.volume10en_US
dc.source.issue7en_US
dc.source.pagenumbere12093en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal